Category: OlympusSyndicate content

Olympus accuses ex-sales manager, ArthroCare | Medtech legal news for the week of June 23, 2014

June 23, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Olympus goes after ex-sales manager, ArthroCare; Stryker alleges Medtronic colluded with patent troll for Kyphon IP; Investors fire life science VC Burrill from his own fund; Patient group wants J&J probe over pelvic mesh

Olympus goes after ex-sales manager, ArthroCare

June 16, 2014 by Brad Perriello

Olympus goes after ex-sales manager, ArthroCare

Olympus concedes biotech defeat, shutters OP-1 plant

June 18, 2014 by Brad Perriello

Olympus Corp. shutters the New Hampshire plant that makes the ill-fated OP-1 bone growth putty it bought from Stryker in 2010, after failing to find a buyer for the business.

Olympus concedes biotech defeat, shutters OP-1 plant

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Olympus goes after ex-sales manager, ArthroCare

June 16, 2014 by Brad Perriello

Olympus sues ArthroCare and a former sales territory manager, accusing Clayton Williard and his new employer of breach of contract and tortious interference.

Olympus goes after ex-sales manager, ArthroCare

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Bakris: Symplicity-3 a prologue for renal denervation | MassDevice.com On Call

April 22, 2014 by MassDevice

Dr. George Bakris, co-principal investigator in Medtronic's Symplicity-3 trial, says renal denervation needs more study before attempting more clinical trials.

MassDevice.com On Call

MASSDEVICE ON CALL — Dr. George Bakris, the co-principal investigator for Medtronic's (NYSE:MDT) failed Symplicty-3 renal denervation trial, believes further clinical work should be tabled until a few key questions about the therapy are answered.

Olympus abandons U.S. biotech biz

March 10, 2014 by Brad Perriello

Japanese tech giant Olympus is shuttering its U.S. biotech business and looking to sell off the New Hampshire plant that makes the OP-1 bone growth putty it bought from Stryker in 2010, spelling layoffs for some 200 workers.

Olympus abandons U.S. biotech biz

Olympus (PINK:OCPNY) said it's shutting down its U.S. biotech business after failing to "gain the traction necessary to build a broader regenerative medicine portfolio," meaning layoffs for the unit's 200 workers.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Judge OKs $2.6M Olympus shareholder settlement

February 5, 2014 by Brad Perriello

A $2.6 million deal to settle a shareholder's lawsuit filed over the $1.7 billion accounting scandal that slashed 50% from Olympus Corp. in 2011.

Judge OKs $2.6M Olympus shareholder lawsuit settlement

A shareholder's lawsuit filed against Olympus (PINK:OCPNY) over a $1.7 billion accounting scandal is slated for a $2.6 million settlement after a federal judge granted preliminary approval to the deal last week.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

GPO: Premier awards Technology Breakthroughs contract to Olympus America

July 31, 2013 by Sony Salzman

Group purchasing organization Premier inked a deal with Olympus America for the company's Thunderbeat surgical tool, signing it up under the GPO’s program for innovative new technologies.

PremierHealthcareAlliance

Olympus America, a Center Valley, Pa.-based commercial camera and medical supply maker, landed a contract to supply surgical tools to members of group purchasing organization Premier healthcare alliance.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp